Tvardi Therapeutics racks up $74m Series B
Tvardi Therapeutics Inc, a biopharmaceutical company, has secured $74 million in Series B financing.
Tvardi Therapeutics Inc, a biopharmaceutical company, has secured $74 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination